All concepts, explanations, trials, and studies have been re-written in plain English and may contain errors. I am not a doctor ----------------------------------------------------------- NOTE: You can make the print bigger with the font button on your browser! (It's usually a big "A") ----------------------------------------------------------- ICDs-Risk_of_CHF_from MADIT-2_study June 12, 2006 - In patients with both an ICD and ischemic cardiomyopathy, the first proper zap greatly increases the risk of a heart failure episode. Strangely, an unneeded or "inappropriate" shock does not affect this risk level at all. Researchers studed the MADIT-2 trial, which was done in 2002. It included 1232 heart attack patients with EF less than 30%. Patients got single-chamber or dual- chamber ICDs; or just took standard meds. The trial was about 20 months long and 24 patients dropped out. Single-chamber ICDs (402 patients) started their pacing action when heart rate went below about 50 beats per minute. Dual-chamber ICDs (313 patients) started pacing at about 60 beats per minute. Researchers say 92% of single-chamber patients had very little or no pacing during the trial. Right-side pacing was happening over 50% of the time in about 66% of dual-chamber patients. Both kinds of ICD raised heart failure risk after the first "appropriate" shock but not after an "inappropriate" shock. This suggests it is not the ICD "zap" itself that raises HF risk. More single-chamber device patients (22%) and dual-chamber patients (25%) had a HF hospitalization than meds-only patients (17%). HF risk was less in device patients taking a beta-blocker. Okay, so what does this mean? Well, you could say that a life-saving ICD shock sort of turns sudden death risk into heart failure risk. So ICD patients should get more aggressive meds therapy and make more aggressive life style changes to lower their risk of HF should their ICDs save them from sudden death. Source: Circulation. 2006 Jun 20;113(24):2810-7. Epub 2006 Jun 12. Title: Causes and consequences of heart failure after prophylactic implantation of a defibrillator in the Multicenter Automatic Defibrillator Implantation Trial II. Authors: Goldenberg I, Moss AJ, Hall WJ, et al.